← Back to all signals

IART INTEGRA LIFESCIENCES HOLDINGS CORP

Last updated: Nov 16, 2026

🐻

Execution Consistency

Did the company actually spend money buying back stock in 3+ of the last 4 quarters?

Bought back stock in only 1/4 quarters. Q3 2026: $0M, Q3 2025: $0M, Q3 2024: $125M, Q2 2024: $0M

🐻

Execution Acceleration

Is the most recent quarter's buyback spend more than 15% above the trailing average?

Latest quarter $0M vs trailing avg $42M (-100%)

🐻

Buyback vs FCF

What percentage of free cash flow is going to buybacks? Bull: 30%+. Bear: negative FCF or no buybacks.

Negative FCF ($-108M), buybacks not supported by cash flow

🐂

Buyback Intensity

How fast are they shrinking the float? Bull: 2%+ annually. Bear: under 0.5%.

Repurchased 5,200,000 shares = 6.7% of 77,800,976 outstanding (annualized)

🐻

Insider Buying

Are officers and directors buying stock with their own money on the open market?

No insider open-market purchases in the last 12 months

—

Insider-Buyback Convergence

Are both company buybacks and insider buying independently active? Bull when the company is buying back stock in 2+ quarters and insiders have made 2+ open-market purchases.

Need both buyback and insider purchase data

—

Insider Net Direction

Over the last 90 days, are insiders net buyers or net sellers on the open market?

No insider open-market transactions in the last 90 days

—

Red Flag

Active buyback + insiders net selling 3x+ more than buying. Company cash may be supporting price while insiders exit.

No buyback-insider divergence detected